<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05036031</url>
  </required_header>
  <id_info>
    <org_study_id>Renji-IIT2021091</org_study_id>
    <nct_id>NCT05036031</nct_id>
  </id_info>
  <brief_title>Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study</brief_title>
  <acronym>TEA-ACLF</acronym>
  <official_title>Liver Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study to Evaluate Different Criterion in Predicting Post-transplant Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The definition and diagnostic criteria of acute-on chronic liver failure (ACLF) differed&#xD;
      evidently between the East and the West due to the difference in the underlying etiology.&#xD;
      Liver transplantation is the most effective treatment to reverse the progress of ACLF and&#xD;
      improve the survival rate of patients. The purpose of this study is to explore the accuracy&#xD;
      of the two diagnostic criteria of EASL-CLIF and APASL ACLF in assessing the survival rate of&#xD;
      patients with liver cirrhosis after LT.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A retrospective collection and analysis of the preoperative conditions of patients with LT&#xD;
      due to cirrhosis in a single center from January 2015 to June 2020 would be conducted,&#xD;
      including epidemiological characteristics, etiology, clinical indicators, and short-term (28&#xD;
      days, 90 days) and long-term (1 year, 3 years) survival after LT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>3 years overall survival</measure>
    <time_frame>Up to ~3 years</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Acute-On-Chronic Liver Failure</condition>
  <condition>Liver Cirrhosis</condition>
  <condition>Liver Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>EASL-CLIF ACLF patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>APASL ACLF patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-ACLF patients</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients underwent liver transplantation for cirrhosis at Renji Hospital, School of&#xD;
        Medicine, Shanghai Jiao Tong University, China between January 2015 and June 2020 were&#xD;
        considered for inclusion.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients underwent liver transplantation for cirrhosis&#xD;
&#xD;
          -  The diagnosis of ACLF followed APASL and EASL-CLIF definition.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with malignant tumor or underwent living donor liver transplantation (LDLT)&#xD;
             were excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiang Xia</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hao Feng</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hao Feng, MD., Ph.D.</last_name>
    <phone>008615000901110</phone>
    <email>surgeonfeng@live.com</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 1, 2021</study_first_submitted>
  <study_first_submitted_qc>September 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute-On-Chronic Liver Failure</keyword>
  <keyword>EASL-CLIF criteria</keyword>
  <keyword>APASL criteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Hepatic Insufficiency</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
    <mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

